Percutaneous extracorporeal life support in acute severe hemodynamic collapses: single centre experience in 100 consecutive patients
…, O Chavanon, R Hacini, H Bouvaist… - The Canadian journal …, 2009 - europepmc.org
MÉTHODES: Registre monocentrique descriptif avec suivi prospectif à 1 an. RÉSULTATS: L’ECLS
a été posée avec succès chez 93% des patients. Son indication était un choc …
a été posée avec succès chez 93% des patients. Son indication était un choc …
Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study
…, E Bergot, EA Macari, H Bouvaist… - European …, 2014 - Eur Respiratory Soc
Patients with severe pulmonary arterial hypertension (PAH) in New York Heart Association (NYHA)
functional class (FC) III/IV have a poor prognosis, despite survival benefits being …
functional class (FC) III/IV have a poor prognosis, despite survival benefits being …
Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open …
X Jaïs, P Brenot, H Bouvaist, M Jevnikar… - The Lancet …, 2022 - thelancet.com
Background Riociguat and balloon pulmonary angioplasty (BPA) are treatment options for
inoperable chronic thromboembolic pulmonary hypertension (CTEPH). However, randomised …
inoperable chronic thromboembolic pulmonary hypertension (CTEPH). However, randomised …
Percutaneous repair or medical treatment for secondary mitral regurgitation: outcomes at 2 years
…, C Zerbib, B Bertrand, H Bouvaist… - European journal of …, 2019 - Wiley Online Library
Aims The MITRA‐FR trial showed that among symptomatic patients with severe secondary
mitral regurgitation, percutaneous repair did not reduce the risk of death or hospitalization for …
mitral regurgitation, percutaneous repair did not reduce the risk of death or hospitalization for …
Prognostic factors for extracorporeal cardiopulmonary resuscitation recipients following out-of-hospital refractory cardiac arrest. A systematic review and meta-analysis
…, E Fournel, M Blancher, H Bouvaist… - Resuscitation, 2017 - Elsevier
Purpose Association estimates between baseline characteristics and outcomes are imprecise
and inconsistent among extracorporeal cardiopulmonary resuscitation (ECPR) recipients …
and inconsistent among extracorporeal cardiopulmonary resuscitation (ECPR) recipients …
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double …
…, Y Mi, X Zhu, P Jansa, G Prévot, H Bouvaist… - The Lancet …, 2024 - thelancet.com
Background Macitentan is beneficial for long-term treatment of pulmonary arterial
hypertension. The microvasculopathy of chronic thromboembolic pulmonary hypertension (CTEPH) …
hypertension. The microvasculopathy of chronic thromboembolic pulmonary hypertension (CTEPH) …
Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness
…, V Planté-Bordeneuve, H Bouvaist… - European heart …, 2016 - academic.oup.com
Aims Increased left ventricular wall thickness (LVWT) is a common finding in cardiology. It is
not known how often hereditary transthyretin-related familial amyloid cardiomyopathy (mTTR…
not known how often hereditary transthyretin-related familial amyloid cardiomyopathy (mTTR…
Association between initial treatment strategy and long-term survival in pulmonary arterial hypertension
…, A Beurnier, A Bourdin, H Bouvaist… - American journal of …, 2021 - atsjournals.org
Rationale: The relationship between the initial treatment strategy and survival in pulmonary
arterial hypertension (PAH) remains uncertain. Objectives: To evaluate the long-term survival …
arterial hypertension (PAH) remains uncertain. Objectives: To evaluate the long-term survival …
Initial dual oral combination therapy in pulmonary arterial hypertension
…, C Chabannes, E Bergot, H Bouvaist… - European …, 2016 - Eur Respiratory Soc
Treatment for pulmonary arterial hypertension (PAH) has been underpinned by single-agent
therapy to which concomitant drugs are added sequentially when pre-defined treatment …
therapy to which concomitant drugs are added sequentially when pre-defined treatment …
Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis
…, PO Collinson, T Keller, H Bouvaist… - European Heart …, 2014 - journals.sagepub.com
Aims: This systematic review aimed to investigate the diagnostic accuracy of combined cardiac
troponin (cTn) and copeptin assessment in comparison to cTn alone for early rule-out of …
troponin (cTn) and copeptin assessment in comparison to cTn alone for early rule-out of …